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Abstract 
Purpose: To evaluate the quality of life of patients with peripheral diabetic neuropathy pain (PDNP) in 
Hospital Tegku Ampaun Afzan (HTAA), Kuantan, Malaysia. 
Methods: Ninety (90) participants were selected from the Medical Outpatient Department (MOPD) clinic 
of HTAA. The study adopted a cross-sectional design, and the self-administered Douleur Neuropathy 4 
(DN4) and Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaires were used for data 
collection. 
Results: The negative impact of diabetes on QoL was clearly reflected in the fact that every domain 
had a negative mean value. Overall, 27.8 % of the participants reported that DM negatively affected 
their QoL and 37.8 % expressed the opinion that their QoL would have been higher if they were not 
diabetic. QoL correlated with marital status and age, with married participants and participants in the 
age range 50 - 59 years old showing QoL negatively affected (p < 0.05) by DM with PDNP. Apart from 
diabetes type, all other characteristics significantly affected participants QoL as reflected by the various 
related domains (p < 0.05). 
Conclusion:  Based on the findings of this study, it seems that individuals with diabetes and PDNP 
have a low QoL, with regard to “freedom to eat”, “freedom to drink”, “physical health”, “family life”, and 
“living condition”. 
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Diabetes mellitus (DM) is one of the diseases 
with greater impact on public health, not only 
because of its high prevalence, but, above all, by 
the consequences of the chronic complications 
arising from this disease [1]. In 2017, the number 
of adults diagnosed with DM at global level was 
425 million, according to the International 
Diabetes Federation (IDF) [2]. If no measures are 
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adopted to deal with this situation, this figure is 
expected to rise to 642 million by 2040 [2]. 
Around 30 % of hospitalised DM patients and 25 
% of DM outpatients develop this condition [3]. 
Clinically, diabetic neuropathy (DN) manifests 
differently at somatic, autonomic and central 
levels and has a massive impact on quality of life 
as well as life expectancy [4]. According to the 
World Health Organisation (WHO), the manner in 
which people perceive their life condition within 
the cultural and value systems that they are living 
in and in relation to their aims, expectations, 
standards and worries is referred to as quality of 
life (QoL) [5]. An essential outcome of diabetes 
care, QoL is measured via the Audit of Diabetes-
Dependent Quality of Life (ADDQoL) tool, which 
aims to determine how patients perceive that 
their QoL has been affected by diabetes [6]. 
Besides being a key outcome on its own, QoL is 
also a key outcome due to its implications for 
patients’ ability to take care of themselves, which 
in turns affects how their diabetes is controlled 
and managed [7]. Knowledge about the QoL of 
individuals suffering from peripheral diabetic 
neuropathy pain (PDNP) is lacking, even though 
this aspect is clearly highly important. The 
relevant practitioners may assess how severe 
the disease is and how far along it advanced, but 
an incompatibility may occur between their 
perspective on patients’ QoL and patients’ 
perception of their QoL [8]. This is why patients’ 
psychological state must be considered when 
inspecting QoL self-assessments [9]. Therefore, 





Setting and participants 
 
To achieve the aim of quantifying the QoL of 
PDNP patients, the study adopted a cross-
sectional design, and the self-administered DN4 
and ADDQoL questionnaires were used for data 
collection. The location from which Ninety (90) 
participants were selected was the Medical 
Outpatient Department (MOPD) clinic of Hospital 
Tegku Ampaun Afzan (HTAA), Kuantan, Pahang, 
Malaysia. To be included in the study, 
participants had to be 18 years of age or older, 
received a DM diagnosis for over a year, and 
could read and write in English or Malay. 
Participants were not included if they suffered 
from a mental condition, like mental disorder, 
dementia, and Alzheimer’s disease, or 
neuropathic pain caused by other diseases. 
Furthermore, to confirm that the pain was due to 
DN, the participants had to exhibit four symptoms 
from the DN4 questionnaire, namely, burning, 
painful coldness, electric shock-like pain and 
painless symptoms like numbness, tingling, 
itching, and pins-and-needles. 
 
Alongside the questionnaires, an information 
sheet was provided to all participants to inform 
them about the research goals. The 
questionnaires were distributed both in English 
and Malay, and the participants were requested 
to fill them out by themselves. No deadline for 
questionnaire completion was set. Participants 
were asked to sign an informed consent form 
(ICF) to confirm their agreement to take part and 
they were also offered the chance to pose any 
questions that they might have had. Besides the 
information derived from the two questionnaires, 
additional information regarding sociodemo-
graphic details and disease characteristics (e.g. 
type, duration, prescribed drugs) was obtained 
during interviews with the participants conducted 
as they waited to be consulted by the specialist. 
 
Ethical consideration  
 
The study was approved by the IIUM Research 
Ethics Committee (IREC-234),  Ministry of Health 
of Malaysia (NMRR-14-188-19549), and  
followed  the International Compilation of Human 
Research Standards [10]. As previously 
mentioned, the researcher informed the 
participants about the study goals and a consent 
form was distributed with the questionnaires. The 
information the participants provided in the 
questionnaires was kept confidential and only the 
collected data were processed. The data were 
not used for any other purpose, academic or 




The ten items in the Douleur Neuropathy 4 (DN4) 
questionnaire were addressed by four questions; 
more specifically, seven of the item pertained to 
pain characterisation (e.g. burning, painful cold, 
electric shocks) and related unusual sensations 
(e.g., tingling, pins and needles, numbness, 
itching), while the remaining three items 
pertained to a succinct bedside neurological 
examination of the zone where pain occurred, 
which involved touch hypoaesthesia using a soft 
brush, pinprick hypoesthesia using disposable 
examination pins, and tactile dynamic allodynia 
using a soft brush. Depending on whether they 
were positive or negative, items were scored 1 or 
0, with the overall possible score being in the 
range 0-10. An overall score of 4 was 
established as the cut-off value for PDNP [11]. 
 
There are two general items that make up the 
ADDQoL questionnaire, namely, one item 
measuring QoL on the whole and another item 
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consisting of 19 subitems inteded to determine 
how particular facets of life are affected by 
diabetes. These facets of life include, work life, 
recreational activities, holidays, local or long-
distance trips, physical health, family life, 
ambitions, friendships and social relationships, 
close personal relationships, sex life, physical 
appearance, self-confidence, living coniditions, 
others’ reactions, outlook on the future, financial 
status, reliance on others, and freedom to eat 
and to drink. In essence, the purpose of these 19 
domains is to help the patients provide an 
assessment of their life and what would it be like 
if they were free from diabetes.  
 
The impact rating for these domains and 
importance rating for perceived importance are in 
the range of -3 to +1 and 0 to +3, respectively. 
The two ratings are multiplied to obtain a 
weighted score for every domain, which could be 
in the range of - 9 to +3. The lower the score, the 
poorer the QoL is. This is followed by the 
calculation of a mean weighted impact score 
(ADDQoL score) for the whole scale across all 
the domains of pertinence [12]. An earlier study 
has evaluated how valid and reliable the 
ADDQoL was, producing values of Cronbach’s 
alpha of 0.945 for the Malay version and 0.907 




The Sample size was calculated using Eq 1.  
 
n = (Z2 x P(1 - P)) / e2 ……………….. (1)  
 
where Z = value from standard normal 
distribution corresponding to desired confidence 
level (Z = 1.96 for 95 % CI), P is expected exact 
proportion, e is desired precision (half desired CI 
width). An additional 10 % was added to the total 
sample for the possibility of incomplete 
questionnaires. The total sample size for our 
study based on these criteria required 85 (77 




The results were expressed as percentages and 
frequencies for categorical variables or by mean 
values and standard deviation for continuous 
variables. Independent samples t-test and one-
way ANOVA were used to examine the 
differences in overall QoL and its domains 
regarding demographic variables and disease-
related data. SPSS  software version  20.0  
(SPSS  Inc,  Chicago, IL, USA) was used for all 
data analysis. P < 0.05 was considered 




Demographic characteristics of study 
participants 
 
Table 1 shows the sociodemographic and clinical 
features of the diabetics with PDNP included in 
this study. According to the results of the 
sociodemographic data analysis, most 
participants were male (60 %) in the age range 
60 - 69 years old (51.1 %), who were married 
(92.2 %), out of work (4.4 %) and with an 
average financial status (51.1 %). Regarding 
clinical characteristics, most participants had 
type 1 diabetes mellitus (T1DM) (64.4 %) and 
had received their diagnosis a decade or more 
ago (44.4 %). Furthermore, 41 of the 90 
participants received solely insulin-based 
treatment (45.6 %), 32 were prescribed oral 
hypoglycemic agents (35.6 %), and 17 received 
a mixture of the other two treatment approaches 
(18.9 %). 
 
Table 1: Socio-demographic and clinical 
characteristics of PDNP 
 
Variables N=90 % 
Gender 54 60 
    Male 36 40 
    Female   
Age group (yr)   
    <50 13 14.4 
    50-59 23 25.6 
    60-69 46 51.1 
    >69 8 8.9 
Occupation   
    Unemployed 50 55.6 
    Employed 40 44.4 
Marital status   
    Married 83 92.2 
    Single 7 7.8 
Economic status   
    Poor 28 31.1 
    Moderate 46 51.1 
    Good 16 17.8 
Type of diabetes   
    Type I 58 64.4 
    Type II 32 35.6 
Duration of diabetes   
    1-4 years 19 21.1 
    5-9 years 31 34.4 
    ≥10 years 40 44.4 
Type of medication   
    OHA only 32 35.6 
    Insulin only 41 45.6 




Impact of diabetes on QoL domains  
 
The negative impact of diabetes on QoL was 
clearly reflected in the fact that every domain had 
a negative mean value. Overall, 27.8 % of the 
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participants reported that DM negatively affected 
their QoL and 37.8 % expressed the opinion that 
their QoL would have been higher if they had not 
been diabetics. Table 2 indicates how the 
answers were distributed and the weights 
allocated to the impact ratings. The domains 
most affected by DM with PDNP were “freedom  
to  eat”  (mean  impact rating:  -2.74 ± 0.53 ), “ 
freedom to drink” (mean  impact rating:  -2.70 ± 
0.46),  “physical health” (mean  impact rating: -
2.49 ± 0.92), “family life” (mean  impact rating:  -
2.24 ± 1.17)  and “living condition” (mean  impact 
rating:  -2.22 ± 1.03). By contrast, the domains 
least affected by DM were “holidays”  (mean  
impact rating: -0.83 ± 1.26),  “physical 
appearance”  (mean  impact rating:  -0.96±1.23),  
“working life” (mean  impact rating:  -1.12 ± 
1.135), “people’s reaction” (mean  impact rating:  
-1.27 ± 1.17) and “sex life” (mean  impact rating:  
-1.32 ± 1.18). Furthermore, the domains that the 
participants attributed the greatest and lowest 
importance were respectively “freedom  to  eat” 
(mean 2.87 ± 0.34) and “dependence on others” 
(mean 0.11 ± 0.31). These two domains were 
also found to be the QoL domains impacted to 
the greatest and least degree by DM, with mean 
-7.95 ± 1.94 for “freedom to eat” and mean -0.27 
± 0.84 for “dependence on others”. 
 
Impact of sociodemographic and clinical 
features on overall QoL score 
 
Table 3 presents the results obtained regarding 
discrepancies in the overall QoL and its domains 
associated with demographic and clinical 
variables. According to the results of the 
independent t-test and one-way ANOVA, QoL 
was found to be correlated with marital status 
and age; thus,  married participants and 
participants in the age range 50 - 59 years old 
had their QoL significantly (p < 0.05) negatively 
affected by DM with PDNP. By contrast, QoL 
was not observed to be statistically significantly 
correlated with gender, occupation, economic 
status, diabetes type or duration, and medication 
type (p > 0.05). 
 
 
Table 2: Distribution of responses (N = 90) by impact and importance rating together with weighted impact score 
 
  Impact rating  Importance 
rating 
 Weighted impact 
score 
 
Q Domain mean± SD (range) mean± SD (range) mean± SD (range) 
1 Leisure activities                          -1.94±1.14 (-3_0)       1.91±1.21     (-3_3)       -4.73±3.71 (-9_3) 
2 Working life -1.12±1.35 (-3_0) 1.22±1.40     (0_3) -3.12±4.02 (-9_0) 
3 Journeys -1.99±1.40 (-3_3) 2.51±0.76     (0_3) -5.51±4.03 (-9_6) 
4 Holidays -0.83±1.26 (-3_0) 0.89±1.29     (0_3) -2.14±3.71 (-9_0) 
5 Physical health -2.49±0.92 (-3_0) 2.63±0.77     (0_3) -7.03±2.90 (-9_0) 
6 Family life -2.24±1.17 (-3_3) 2.54±0.85     (0_3) -6.17±3.43 (-9_0) 
7 Friendship and 
social life              
-1.76±1.11 (-3_0) 1.64±1.06     (0_3) -3.73±3.37 (-9_0) 
8 Personal 
relationship 
-1.48±1.14 (-3_0) 1.67±1.02     (0_3) -3.45±3.47 (-9_0) 
9 Sex life -1.32±1.18 (-3_3) 1.44±0.86     (0_3) -2.47±2.99 (-9_6) 
10 Physical 
appearance 
 -0.96±1.23 (-3_0) 1.36±1.23     (0_3) -2.21±3.35 (-9_0) 
11 Self-confidence -1.49±1.15      (-3_0) 1.61±1.12     (0_3) -3.22±3.50 (-9_0) 
12 Motivation -1.38±1.23 (-3_3) 1.54±1.12   (0_3) -2.98±3.33 (-9_0) 
13 People’s reaction -1.27±1.17      (-3_0) 1.37±1.08     (0_3) -2.63±3.39 (-9_0) 
14 Feeling about 
future 
-1.79±1.17      (-3_0) 1.62±1.16     (0_3) -3.85±3.54 (-9_0) 
15 Financial 
situation 
-1.83±1.16      (-3_0) 2.04±1.14     (0_3) -4.31±3.80 (-9_0) 
16 Living condition -2.22± 1.03     (-3_0) 2.51±0.83     (0_3) -6.05±3.40 (-9_0) 
17 Dependence on 
others 
-1.88± 1.21     (-3_0) 0.11±0.31     (0_3) -0.27±0.84 (-3_0) 
18 Freedom to eat -2.74±0.53      (-3_0) 2.87±0.34 (2_3) -7.95±1.94 (-9_0) 
19 Freedom to 
drink                       
-2.70±0.46      (-3_-2) 2.73±0.46    (1_3) -7.47±2.04 (-9_-2) 
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Table 3: Average weighted impact scores by socio-
demographic and clinical characteristics of diabetic 
patients with PDNP 
 
                                    Average weighted impact 
score 
Variable Mean ± SD P-value                   
Gender  0.814 
    Male -4.13± 1.77  
    Female -4.24± 2.25  
Age group (yr)  0.017 
    <50 -4.15± 1.28  
    50-59 -4.94± 2.22*  
    60-69 -4.10± 1.97  
    >69 -2.43± 0.73  
Occupation  0.903 
    Unemployed -4.20± 2.16  
    Employed -4.15± 1.72   
Marital status  0.000 
    Married -4.28± 2.00*  
    Single -2.89± 0.62  
Economic status  0.122 
    Poor -3.95± 1.52  
    Moderate -3.99± 2.00  
    Good -5.09± 2.37  
Type of diabetes  0.171 
    Type I -4.39± 1.95  
    Type II -3.79± 1.96  
Duration of diabetes  0.157 
    1-4 years -4.04± 1.61  
    5-9 years -4.71± 2.15  
    ≥10 years -3.82± 1.92  
Type of medication  0.067 
    OHA only -3.79± 1.96  
    Insulin only -4.69± 2.04  
    Combination    
(biguanide+insulin) 
-3.64± 1.54  
 
Impact of sociodemographic and clinical 
features on QoL domains 
 
Table 4 lists the average weighted impact scores 
associated with participants’ sociodemographic 
and clinical characteristics (i.e., gender, age 
group, occupation, marital status, economic 
status, diabetes type and duration, and type of 
medication). Apart from diabetes type, all other 
characteristics significantly affected participants 
QoL as reflected by the various related domains 




Overall, the results of the ADDQoL questionnaire 
revealed that every domain related to 
participants’ QoL was adversely affected by 
diabetes. As far as the researcher is aware, no 
other study has addressed the QoL of individuals 
with diabetes and PDNP in Malaysia. To 
determine the QoL of these individuals, the study 
investigated their sociodemographic and clinical 
features, and found that the participants’ QoL 
was low-to-moderate, according to the mean 
score of the overall QoL and related domains. 
The study employed the popular tool of ADDQoL 
questionnaire to gain a comprehensive 
understanding of QoL among individuals with 
diabetes [12,13,15].  
 
The findings revealed that the QoL domain of 
“freedom to eat” was adversely affected by 
diabetes to the highest degree, reflecting the 
major impact of diet limitations on QoL. This 
corroborated the results of previous studies 
[16,17]. Furthermore, diabetes with PDNP also 
had a significant negative effect on the QoL 
domain “freedom to drink”. By contrast, the 
lowest impact of diabetes was recorded in the 
case of the “holiday” domain. This was 
inconsistent with the findings of earlier studies 
[13,15], which reported that the domains least 
impacted were “people’s reaction” and “working 
life”. 
 
Solely age and marital status out of participants’ 
sociodemographic and clinical features were 
found to significantly impact QoL, as indicated by 
the average weighted impact scores. Individuals 
with ages between 50 and 59 years old were 
more likely to experience a lower QoL. This was 
consistent with the findings of two other studies 
[18,19], which reported a direct correlation 
between younger age and lower ADDQoL scores 
as well as a more extensive adverse effect on 
QoL among individuals with diabetes. This 
paradox may be due to the fact that, unlike older 
diabetics, younger diabetics are more anxious 
about their future and the implications of their 
disease for their life [12]. In addition, a close 
correlation between marital status and poorer 
QoL was also observed in the present study. 
This was inconsistent with the result of a 
previous study [18], which did not find a 
significant correlation between marital status and 
lower ADDQoL scores. The reason for this might 
be due to the fact that diabetics’ sexual activity 
might be diminished by PDN. 
 
Many of the 19 domains in the ADDQoL 
questionnaire were significantly affected by the 
participants’ sociodemographic and disease 
features. However, among the two genders, a 
higher QoL was registered in the case of male 
participants. Indeed, the “living condition” domain 
was significantly impacted by the variable of 
male gender, while the “motivation”, “people’s 
reaction” and “feeling about future” domains were 
significantly impacted by the variable of female 
gender. Other studies also reported that male 
diabetics enjoyed a better QoL compared to 
female diabetics [20]. 
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Table 4: Impact of socio-demographic and clinical characteristics on individual life domains 
 
Item of significance Variable  (mean ± SD) P-value 
                               Gender 
 Male Female  
Motivation -2.35±3.06 -3.94±3.53* 0.031 
People’s reaction -1.94±3.04 -3.66±3.66* 0.023 
Feeling about future -3.25±3.65 -4.75±3.22* 0.045 
Living condition -6.74±3.10* -5.02±3.61 0.023 
 Age group (yr)  
 < 50 50-59 60-69 >69  
Holidays -0.07±0.277 -3.26±4.23* -2.54±3.94 - 0.023 
Friendship and social life -3.92±3.49 -5.69±3.67* -3.17±2.92 -1.00±1.85 0.002 
Personal relationship -2.00±3.16 -5.78±3.55* -3.13±3.14 -1.00±1.85 0.000 
Sex life -1.76±3.32 -3.86±2.75* -2.39±2.99 -0.12± 0.35 0.012 
Physical appearance -2.53±3.23 -3.86±3.59* -1.65±3.24 -0.12±0.35 0.015 
Self-confidence -4.30± 3.63 -5.30± 3.87* -2.34± 2.93 -0.50± 0.75 0.000 
Motivation -4.15±3.78 -4.52±3.57* -2.39±2.91 -0.12±0.35 0.002 
Feeling about future -5.38±3.37 -6.00±2.71* -2.97±3.48 -0.25±0.46 0.000 
Financial situation -5.23±3.13* -4.65±4.16 -4.58±3.75 -0.25±0.70 0.014 
                    Occupation   
 Unemployed Employed  
Working life -1.40± 3.21 -5.27± 3.92* 0.000 
Physical appearance -2.88± 3.67* -1.37± 2.71* 0.028 
Self-confidence -3.88± 3.69* -2.40± 3.10 0.042 
 Marital status  
 Married Single  
Friendship and social life -3.92± 3.41* -1.42± 1.90 0.012 
Personal relationship -3.62± 3.52* -1.42± 1.90 0.023 
Sex life -2.63± 3.06* -0.57± 0.78 0.000 
Physical appearance                                 -2.37± 3.43* -0.28± 0.48 0.000 
Self-confidence -3.46± 3.53* -0.28±0.48 0.000 
Motivation -3.21± 3.37* -0.28±0.48 0.000 
People’s reaction -2.83± 3.45* -0.28±0.48 0.000 
Feeling about future -4.16± 3.51* -0.14± 0.37 0.000 
Financial situation -4.56± 3.80* -1.28± 2.21 0.006 
Living condition                      -5.90±3.45 -7.85± 2.03* 0.048 
 Economic status  
 Poor Moderate Good  
Working life -2.92±3.72 -2.47±3.88 -5.31±4.42* 0.049 
Living condition -6.80±3.22 -5.08±3.40 -7.37±2.80* 0.018 
Freedom to eat                           -7.53±1.95 -8.56±1.32* -6.93±2.76 0.005 
 Duration of diabetes (yr)  
 1-4 5-9 >10   
Leisure activities -2.78±2.37 -5.12±3.81 -5.35±3.91* 0.034 
People’s reaction -2.10±3.03 -4.16±3.88* -1.70±2.74 0.006 
Financial situation -5.36±3.98* -5.22±3.59 -3.10±3.60 0.024 
 Type of medication  
 OHA only Insulin only Combination  
Leisure activities -3.81±3.47 -5.92±3.43* -3.58±4.13 0.018 
Physical appearance -1.81±3.12 -3.09±3.67* -0.82±2.32 0.042 
 Type of diabetes  
 Type I Type II  
All items  - -  > 0.05 
 
Furthermore, by contrast to participants younger 
than 60 years of age, those older than 60 years 
of age had a better social life. Meanwhile, an 
earlier study revealed that a higher QoL was 
enjoyed by diabetics younger than 50 years of 
age [17]. 
 
Four of the 19 domains were significantly affect- 
ed by the clinical characteristics of diabetes 
duration and types of medication. More 
specifically, the domains of “financial situation”, 
“people’s reaction”, and “leisure activities” were 
affected by diabetes duration. Conversely, an 
earlier study [17] reported that it was the “self-
confidence”, “sexual life” and “holidays” domains 
that were significantly affected by diabetes 
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duration. Meanwhile, in the present study, 
“leisure activities” and “physical appearance” 
were adversely impacted by insulin treatment.  
 
Again, this result differed from that of earlier 
studies [21,22], which found that the QoL 
domains affected by insulin treatment were 
“family relationships”, “sex life”, “travel”, and 
“family future”. These inconsistencies between 
the present study and earlier ones might be due 
to cultural and context-related aspects, 
discrepancies in participants’ sociodemographic 
characteristics, and differences in the 
assessment tools employed [23]. 
 
Limitations of the study 
 
Generalisation of the study results to the wider 
population of Kuantan was not possible because 
data were collected from just one, albeit major, 
hospital in the city. The study results might also 
be somewhat distorted by the fact that data were 
derived from self-reported questionnaires, which 
present the risk of participants underestimating 




The findings of this study indicate that individuals 
with diabetes and PDNP have a low QoL, 
particularly, with regard to “freedom to eat”, 
“freedom to drink”, “physical health”, “family life”, 
and “living condition”. Certain ADDQoL domain 
scores are adversely impacted by factors such 
as female sex, younger age, lack of employment, 
marriage, good financial position, diabetes 
duration, and insulin-based treatment.  
 
Therefore, not all domains are equally affected 
by the same sociodemographic and clinical 
features. This fact must be taken into account to 
effectively address each patient’s needs. Doctors 
and healthcare practitioners may find these 
results useful in formulating effective approaches 
and strategies for enhancing patients’ QoL. To 
further reinforce the results, the study should be 
repeated on a larger scale with a longer follow-up 
interval. Future studies should also address the 
management of individuals suffering from PDNP 
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